1-15 of 15
Pierfrancesco Tassone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2288.
https://doi.org/10.1158/1078-0432.CCR-24-1089
Published: 15 May 2024
View article titled, Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for Editor's Note: A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Journal Articles

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells

Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, Santo Giovanni Lio, Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (5): 1222–1233.
https://doi.org/10.1158/1078-0432.CCR-15-0489
Published: 29 February 2016
View article titled, A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
Open the PDF for A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells in another window
Includes: Supplementary data
Journal Articles

microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters

Massimo Negrini, Giovanna Cutrona, Cristian Bassi, Sonia Fabris, Barbara Zagatti, Monica Colombo, Manuela Ferracin, Lucilla D'Abundo, Elena Saccenti, Serena Matis, Marta Lionetti, Luca Agnelli, Massimo Gentile, Anna Grazia Recchia, Sabrina Bossio, Daniele Reverberi, Gianmatteo Rigolin, George A. Calin, Silvia Sabbioni, Giandomenico Russo, Pierfrancesco Tassone, Fortunato Morabito, Manlio Ferrarini, Antonino Neri
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (15): 4141–4153.
https://doi.org/10.1158/1078-0432.CCR-13-2497
Published: 31 July 2014
View article titled, microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters
Open the PDF for microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters in another window
Includes: Supplementary data
Journal Articles

Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features

Fortunato Morabito, Laura Mosca, Giovanna Cutrona, Luca Agnelli, Giacomo Tuana, Manuela Ferracin, Barbara Zagatti, Marta Lionetti, Sonia Fabris, Francesco Maura, Serena Matis, Massimo Gentile, Ernesto Vigna, Monica Colombo, Carlotta Massucco, Anna Grazia Recchia, Sabrina Bossio, Laura De Stefano, Fiorella Ilariucci, Caterina Musolino, Stefano Molica, Francesco Di Raimondo, Agostino Cortelezzi, Pierfrancesco Tassone, Massimo Negrini, Sara Monti, Davide Rossi, Gianluca Gaidano, Manlio Ferrarini, Antonino Neri
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (21): 5890–5900.
https://doi.org/10.1158/1078-0432.CCR-13-0622
Published: 31 October 2013
View article titled, Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features
Open the PDF for Clinical Monoclonal B Lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: A Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features in another window
Includes: Supplementary data
Journal Articles

Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome

Katia Todoerti, Luca Agnelli, Sonia Fabris, Marta Lionetti, Giacomo Tuana, Laura Mosca, Luigia Lombardi, Vitina Grieco, Gabriella Bianchino, Fiorella D'Auria, Teodora Statuto, Carmela Mazzoccoli, Luciana De Luca, Maria Teresa Petrucci, Fortunato Morabito, Massimo Offidani, Francesco Di Raimondo, Antonietta Falcone, Paola Omede', Pierfrancesco Tassone, Mario Boccadoro, Antonio Palumbo, Antonino Neri, Pellegrino Musto
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (12): 3247–3258.
https://doi.org/10.1158/1078-0432.CCR-12-3461
Published: 13 June 2013
View article titled, Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome
Open the PDF for Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer Outcome in another window
Includes: Supplementary data
Journal Articles

Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia

Marta Lionetti, Pellegrino Musto, Maria Teresa Di Martino, Sonia Fabris, Luca Agnelli, Katia Todoerti, Giacomo Tuana, Laura Mosca, Maria E. Gallo Cantafio, Vitina Grieco, Gabriella Bianchino, Fiorella D'Auria, Teodora Statuto, Carmela Mazzoccoli, Luciana De Luca, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Antonietta Falcone, Tommaso Caravita, Paola Omede', Fortunato Morabito, Pierfrancesco Tassone, Mario Boccadoro, Antonio Palumbo, Antonino Neri
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (12): 3130–3142.
https://doi.org/10.1158/1078-0432.CCR-12-2043
Published: 13 June 2013
View article titled, Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia
Open the PDF for Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia in another window
Includes: Supplementary data
Journal Articles

Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth

Emanuela Leone, Eugenio Morelli, Maria T. Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2096–2106.
https://doi.org/10.1158/1078-0432.CCR-12-3325
Published: 15 April 2013
View article titled, Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth
Open the PDF for Targeting miR-21 Inhibits <em>In Vitro</em> and <em>In Vivo</em> Multiple Myeloma Cell Growth in another window
Includes: Supplementary data
Journal Articles

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

Maria T. Di Martino, Emanuela Leone, Nicola Amodio, Umberto Foresta, Marta Lionetti, Maria R. Pitari, Maria E. Gallo Cantafio, Annamaria Gullà, Francesco Conforti, Eugenio Morelli, Vera Tomaino, Marco Rossi, Massimo Negrini, Manlio Ferrarini, Michele Caraglia, Masood A. Shammas, Nikhil C. Munshi, Kenneth C. Anderson, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6260–6270.
https://doi.org/10.1158/1078-0432.CCR-12-1708
Published: 14 November 2012
View article titled, Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence
Open the PDF for Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <em>In Vitro</em> and <em>In Vivo</em> Evidence in another window
Includes: Supplementary data
Journal Articles

Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response

Sabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, Anna Colpo, Laura Pavan, Anna Cabrelle, Elisa Ave, Fortunato Zaffino, Giovanni Di Maira, Maria Ruzzene, Fausto Adami, Renato Zambello, Maria Rita Pitari, Pierfrancesco Tassone, Lorenzo A. Pinna, Carmela Gurrieri, Gianpietro Semenzato, Francesco Piazza
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 1888–1900.
https://doi.org/10.1158/1078-0432.CCR-11-1789
Published: 01 April 2012
View article titled, Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response
Open the PDF for Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response in another window
Includes: Supplementary data
Journal Articles

Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma

Pierpaolo Correale, Maria Saveria Rotundo, Cirino Botta, Maria Teresa Del Vecchio, Chiara Ginanneschi, Antonella Licchetta, Raffaele Conca, Serena Apollinari, Fabio De Luca, Pierfrancesco Tassone, Pierosandro Tagliaferri
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 850–857.
https://doi.org/10.1158/1078-0432.CCR-10-3186
Published: 31 January 2012
View article titled, Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
Open the PDF for Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma in another window
Journal Articles

Significant Biological Role of Sp1 Transactivation in Multiple Myeloma

Mariateresa Fulciniti, Samir Amin, Puru Nanjappa, Scott Rodig, Rao Prabhala, Cheng Li, Stephane Minvielle, Yu-tzu Tai, Pierfrancesco Tassone, Herve Avet-Loiseau, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6500–6509.
https://doi.org/10.1158/1078-0432.CCR-11-1036
Published: 14 October 2011
View article titled, Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
Open the PDF for Significant Biological Role of Sp1 Transactivation in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma

Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, Samantha Pozzi, Puru Nanjappa, Zhenxin Shen, Nipun Patel, Ernest S. Smith, Wei Wang, Rao Prabhala, Yu-tzu Tai, Pierfrancesco Tassone, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7144–7152.
https://doi.org/10.1158/1078-0432.CCR-09-1483
Published: 30 November 2009
View article titled, A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Open the PDF for A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma in another window
Journal Articles

Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)

Pierpaolo Correale, Pierosandro Tagliaferri, Antonella Fioravanti, Maria Teresa Del Vecchio, Cinzia Remondo, Francesco Montagnani, Maria Saveria Rotundo, Chiara Ginanneschi, Ignazio Martellucci, Edoardo Francini, Maria Grazia Cusi, Pierfrancesco Tassone, Guido Francini
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4192–4199.
https://doi.org/10.1158/1078-0432.CCR-07-5278
Published: 01 July 2008
View article titled, Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)
Open the PDF for Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial) in another window
Journal Articles

Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model

Paola Neri, Shaji Kumar, Maria Teresa Fulciniti, Sonia Vallet, Shweta Chhetri, Sidhartha Mukherjee, YuTzu Tai, Dharminder Chauhan, Pierfrancesco Tassone, Salvatore Venuta, Nikhil C. Munshi, Teru Hideshima, Kenneth C. Anderson, Noopur Raje
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5903–5909.
https://doi.org/10.1158/1078-0432.CCR-07-0753
Published: 01 October 2007
View article titled, Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model
Open the PDF for Neutralizing B-Cell–Activating Factor Antibody Improves Survival and Inhibits Osteoclastogenesis in a Severe Combined Immunodeficient Human Multiple Myeloma Model in another window
Journal Articles

Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu In vivo Model of Human Multiple Myeloma

Pierfrancesco Tassone, Paola Neri, Renate Burger, Rocco Savino, Masood Shammas, Laurence Catley, Klaus Podar, Dharminder Chauhan, Serena Masciari, Antonella Gozzini, Pierosandro Tagliaferri, Salvatore Venuta, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 4251–4258.
https://doi.org/10.1158/1078-0432.CCR-04-2611
Published: 01 June 2005
View article titled, Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu <em>In vivo</em> Model of Human Multiple Myeloma
Open the PDF for Combination Therapy with Interleukin-6 Receptor Superantagonist Sant7 and Dexamethasone Induces Antitumor Effects in a Novel SCID-hu <em>In vivo</em> Model of Human Multiple Myeloma in another window